|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 2 (January 15), 1999:
pp. 467-480
Comparison of Immune Reconstitution After Unrelated and Related
T-Cell-Depleted Bone Marrow Transplantation: Effect of Patient
Age and Donor Leukocyte Infusions
T.N. Small,
E.B. Papadopoulos,
F. Boulad,
P. Black,
H. Castro-Malaspina,
B.H. Childs,
N. Collins,
A. Gillio,
D. George,
A. Jakubowski,
G. Heller,
M. Fazzari,
N. Kernan,
S. MacKinnon,
P. Szabolcs,
J.W. Young, and
R.J. O'Reilly
From Memorial Sloan-Kettering Cancer Center, New York, NY.
Unrelated bone marrow transplantation (BMT) is often complicated by
fatal opportunistic infections. To evaluate features unique to immune
reconstitution after unrelated BMT, the lymphoid phenotype, in vitro
function, and life-threatening opportunistic infections after unrelated
and related T-cell-depleted (TCD) BMT were analyzed longitudinally and compared. The effects of posttransplant donor leukocyte infusions to treat or prevent cytomegalovirus (CMV) or
Epstein-Barr virus (EBV) infections on immune
reconstitution were also analyzed. This study demonstrates that adult
recipients of TCD unrelated BMTs experience prolonged and profound
deficiencies of CD3+, CD4+, and
CD8+ T-cell populations when compared with pediatric
recipients of unrelated BMT and adults after related BMT (P < .01), that these adults have a significantly increased risk of
life-threatening opportunistic infections, and that the rate of
recovery of CD4 T cells correlates with the risk of developing these
infections. Recovery of normal numbers of CD3+,
CD8+, and CD4+ T-cell populations is
similar in children after related or unrelated BMT. This study also
demonstrates that adoptive immunotherapy with small numbers of
unirradiated donor leukocytes can be associated with rapid restoration
of CD3+, CD4+, and CD8+
T-cell numbers, antigen-specific T-cell responses, and resolution of
CMV- and EBV-associated disease after unrelated TCD BMT.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Leen, A. Christin, G. D. Myers, H. Liu, C. R. Cruz, P. J. Hanley, A. A. Kennedy-Nasser, K. S. Leung, A. P. Gee, R. A. Krance, et al.
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
Blood,
November 5, 2009;
114(19):
4283 - 4292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R Lorenzi, T A Morgan, A Anderson, J Catterall, A M Patterson, H E Foster, and J D Isaacs
Thymic function in juvenile idiopathic arthritis
Ann Rheum Dis,
June 1, 2009;
68(6):
983 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Goldberg, C. G. King, R. A. Nejat, D. Y. Suh, O. M. Smith, J. C. Bretz, R. M. Samstein, J. A. Dudakov, A. P. Chidgey, S. Chen-Kiang, et al.
Luteinizing Hormone-Releasing Hormone Enhances T Cell Recovery following Allogeneic Bone Marrow Transplantation
J. Immunol.,
May 1, 2009;
182(9):
5846 - 5854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. O. Alpdogan, S. X. Lu, N. Patel, S. McGoldrick, D. Suh, T. Budak-Alpdogan, O. M. Smith, J. Grubin, C. King, G. L. Goldberg, et al.
Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation
Blood,
December 1, 2008;
112(12):
4755 - 4764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Williams, P. J. Lucas, C. V. Bare, J. Wang, Y.-W. Chu, E. Tayler, V. Kapoor, and R. E. Gress
CCL25 increases thymopoiesis after androgen withdrawal
Blood,
October 15, 2008;
112(8):
3255 - 3263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Hossain, J. D. Roback, F. Wang, and E. K. Waller
Host and Donor Immune Responses Contribute to Antiviral Effects of Amotosalen-Treated Donor Lymphocytes following Early Posttransplant Cytomegalovirus Infection
J. Immunol.,
May 15, 2008;
180(10):
6892 - 6902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Jakubowski, T. N. Small, J. W. Young, N. A. Kernan, H. Castro-Malaspina, K. C. Hsu, M.-A. Perales, N. Collins, C. Cisek, M. Chiu, et al.
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
Blood,
December 15, 2007;
110(13):
4552 - 4559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Popa, I. Zubkova, M. Medvedovic, T. Romantseva, H. Mostowski, R. Boyd, and M. Zaitseva
Regeneration of the adult thymus is preceded by the expansion of K5+K8+ epithelial cell progenitors and by increased expression of Trp63, cMyc and Tcf3 transcription factors in the thymic stroma
Int. Immunol.,
November 1, 2007;
19(11):
1249 - 1260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Burges, P. Wimberger, C. Kumper, V. Gorbounova, H. Sommer, B. Schmalfeldt, J. Pfisterer, M. Lichinitser, A. Makhson, V. Moiseyenko, et al.
Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM x Anti-CD3 Antibody: A Phase I/II Study
Clin. Cancer Res.,
July 1, 2007;
13(13):
3899 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Seggewiss, K. Lore, F. J. Guenaga, S. Pittaluga, J. Mattapallil, C. K. Chow, R. A. Koup, K. Camphausen, M. C. Nason, M. Meier-Schellersheim, et al.
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.
Blood,
July 1, 2007;
110(1):
441 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-J. Wils, E. Braakman, G. M. G. M. Verjans, E. J. C. Rombouts, A. E. C. Broers, H. G. M. Niesters, G. Wagemaker, F. J. T. Staal, B. Lowenberg, H. Spits, et al.
Flt3 Ligand Expands Lymphoid Progenitors Prior to Recovery of Thymopoiesis and Accelerates T Cell Reconstitution after Bone Marrow Transplantation
J. Immunol.,
March 15, 2007;
178(6):
3551 - 3557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Min, A. Panoskaltsis-Mortari, M. Kuro-o, G. A. Hollander, B. R. Blazar, and K. I. Weinberg
Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging
Blood,
March 15, 2007;
109(6):
2529 - 2537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Brunstein, D. J. Weisdorf, T. DeFor, J. N. Barker, J. Tolar, J.-A. H. van Burik, and J. E. Wagner
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
Blood,
October 15, 2006;
108(8):
2874 - 2880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jaffe, E. B. Papadopoulos, J. W. Young, R. J. O'Reilly, S. Prockop, N. A. Kernan, A. Jakubowski, F. Boulad, M.-A. Perales, H. Castro-Malaspina, et al.
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants
Blood,
October 1, 2006;
108(7):
2470 - 2475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Perales, A. Diab, A. D. Cohen, D. W. Huggins, J. A. Guevara-Patino, V. M. Hubbard, M. E. Engelhorn, A. A. Kochman, J. M. Eng, F. Mortazavi, et al.
DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation
J. Immunol.,
September 15, 2006;
177(6):
4159 - 4167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Amrolia, G. Muccioli-Casadei, H. Huls, S. Adams, A. Durett, A. Gee, E. Yvon, H. Weiss, M. Cobbold, H. B. Gaspar, et al.
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation
Blood,
September 15, 2006;
108(6):
1797 - 1808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Alpdogan, V. M. Hubbard, O. M. Smith, N. Patel, S. Lu, G. L. Goldberg, D. H. Gray, J. Feinman, A. A. Kochman, J. M. Eng, et al.
Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration
Blood,
March 15, 2006;
107(6):
2453 - 2460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. de Kleer, B. Vastert, M. Klein, G. Teklenburg, G. Arkesteijn, G. P. Yung, S. Albani, W. Kuis, N. Wulffraat, and B. Prakken
Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network
Blood,
February 15, 2006;
107(4):
1696 - 1702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Hsu, C. A. Keever-Taylor, A. Wilton, C. Pinto, G. Heller, K. Arkun, R. J. O'Reilly, M. M. Horowitz, and B. Dupont
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes
Blood,
June 15, 2005;
105(12):
4878 - 4884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Watson, G. Y. Zhang, M. Sartor, and S. I. Alexander
"Pruning" of Alloreactive CD4+ T Cells Using 5- (and 6-)Carboxyfluorescein Diacetate Succinimidyl Ester Prolongs Skin Allograft Survival
J. Immunol.,
December 1, 2004;
173(11):
6574 - 6582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Foster, M. Marangolo, M. M. Sartor, S. I. Alexander, M. Hu, K. F. Bradstock, and D. J. Gottlieb
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion
Blood,
October 15, 2004;
104(8):
2403 - 2409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gendelman, T. Hecht, B. Logan, S. Vodanovic-Jankovic, R. Komorowski, and W. R. Drobyski
Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease
J. Immunol.,
March 1, 2004;
172(5):
3328 - 3336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ljungman, R. Brand, H. Einsele, F. Frassoni, D. Niederwieser, and C. Cordonnier
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis
Blood,
December 15, 2003;
102(13):
4255 - 4260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Poulin, M. Sylvestre, P. Champagne, M.-L. Dion, N. Kettaf, A. Dumont, M. Lainesse, P. Fontaine, D.-C. Roy, C. Perreault, et al.
Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
Blood,
December 15, 2003;
102(13):
4600 - 4607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nikiforow, K. Bottomly, G. Miller, and C. Munz
Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation
J. Virol.,
November 15, 2003;
77(22):
12088 - 12104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bachar-Lustig, S. Reich-Zeliger, and Y. Reisner
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose
Blood,
September 15, 2003;
102(6):
1943 - 1950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. C. Broers, S. J. Posthumus-van Sluijs, H. Spits, B. van der Holt, B. Lowenberg, E. Braakman, and J. J. Cornelissen
Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants
Blood,
August 15, 2003;
102(4):
1534 - 1540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Grewal, J. N. Barker, S. M. Davies, and J. E. Wagner
Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?
Blood,
June 1, 2003;
101(11):
4233 - 4244.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Socie, N. Salooja, A. Cohen, A. Rovelli, E. Carreras, A. Locasciulli, E. Korthof, J. Weis, V. Levy, and A. Tichelli
Nonmalignant late effects after allogeneic stem cell transplantation
Blood,
May 1, 2003;
101(9):
3373 - 3385.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Lewin, G. Heller, L. Zhang, E. Rodrigues, E. Skulsky, M. R. M. van den Brink, T. N. Small, N. A. Kernan, R. J. O'Reilly, D. D. Ho, et al.
Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations
Blood,
August 28, 2002;
100(6):
2235 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. H. M. Van Hoef ; and S. Mackinnon
Nonmyeloablative transplantation challenged by experimentation
Blood,
July 30, 2002;
100(4):
1508 - 1509.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chakrabarti, S. Mackinnon, R. Chopra, P. D. Kottaridis, K. Peggs, P. O'Gorman, R. Chakraverty, T. Marshall, H. Osman, P. Mahendra, et al.
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution
Blood,
May 29, 2002;
99(12):
4357 - 4363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bellucci, E. P. Alyea, E. Weller, A. Chillemi, E. Hochberg, C. J. Wu, C. Canning, R. Schlossman, R. J. Soiffer, K. C. Anderson, et al.
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
Blood,
May 29, 2002;
99(12):
4610 - 4617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Hazenberg, S. A. Otto, E. S. de Pauw, H. Roelofs, W. E. Fibbe, D. Hamann, and F. Miedema
T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events
Blood,
May 1, 2002;
99(9):
3449 - 3453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Okamoto, D. C. Douek, R. D. McFarland, and R. A. Koup
Effects of exogenous interleukin-7 on human thymus function
Blood,
April 15, 2002;
99(8):
2851 - 2858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Castro-Malaspina, R. E. Harris, J. Gajewski, N. Ramsay, R. Collins, B. Dharan, R. King, and H. J. Deeg
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program
Blood,
March 15, 2002;
99(6):
1943 - 1951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Talvensaari, E. Clave, C. Douay, C. Rabian, L. Garderet, M. Busson, F. Garnier, D. Douek, E. Gluckman, D. Charron, et al.
A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation
Blood,
February 15, 2002;
99(4):
1458 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chakraverty, K. Peggs, R. Chopra, D. W. Milligan, P. D. Kottaridis, S. Verfuerth, J. Geary, D. Thuraisundaram, K. Branson, S. Chakrabarti, et al.
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen
Blood,
February 1, 2002;
99(3):
1071 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. de Gast, F. A. Vyth-Dreese, W. Nooijen, C. J.C. van den Bogaard, J. Sein, M. M.J. Holtkamp, G. A.M. Linthorst, J. W. Baars, J. H. Schornagel, and S. Rodenhuis
Reinfusion of Autologous Lymphocytes With Granulocyte-Macrophage Colony-Stimulating Factor Induces Rapid Recovery of CD4+ and CD8+ T Cells After High-Dose Chemotherapy for Metastatic Breast Cancer
J. Clin. Oncol.,
January 1, 2002;
20(1):
58 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Alpdogan, C. Schmaltz, S. J. Muriglan, B. J. Kappel, M.-A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. M. van den Brink
Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease
Blood,
October 1, 2001;
98(7):
2256 - 2265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chung, L. Barbara-Burnham, L. Barsky, and K. Weinberg
Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation
Blood,
September 1, 2001;
98(5):
1601 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rocha, J. Cornish, E. L. Sievers, A. Filipovich, F. Locatelli, C. Peters, M. Remberger, G. Michel, W. Arcese, S. Dallorso, et al.
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
Blood,
May 15, 2001;
97(10):
2962 - 2971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Volpi, K. Perruccio, A. Tosti, M. Capanni, L. Ruggeri, S. Posati, F. Aversa, A. Tabilio, L. Romani, M. F. Martelli, et al.
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants
Blood,
April 15, 2001;
97(8):
2514 - 2521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hebart, W. Brugger, U. Grigoleit, B. Gscheidle, J. Loeffler, H. Schafer, L. Kanz, H. Einsele, and C. Sinzger
Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality
Blood,
April 1, 2001;
97(7):
2183 - 2185.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Weinberg, B. R. Blazar, J. E. Wagner, E. Agura, B. J. Hill, M. Smogorzewska, R. A. Koup, M. R. Betts, R. H. Collins, and D. C. Douek
Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation
Blood,
March 1, 2001;
97(5):
1458 - 1466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gottschalk, C. Y. C. Ng, M. Perez, C. A. Smith, C. Sample, M. K. Brenner, H. E. Heslop, and C. M. Rooney
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
Blood,
February 15, 2001;
97(4):
835 - 843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Sullivan, C. A. Dykewicz, D. L. Longworth, M. Boeckh, L. R. Baden, R. H. Rubin, and K. A. Sepkowitz
Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond
Hematology,
January 1, 2001;
2001(1):
392 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Muller, T. Kohn, A. S. Schulz, K.-M. Debatin, and W. Friedrich
Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation
Blood,
December 15, 2000;
96(13):
4344 - 4349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eckle, L. Prix, G. Jahn, T. Klingebiel, R. Handgretinger, B. Selle, and K. Hamprecht
Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes
Blood,
November 1, 2000;
96(9):
3286 - 3289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Thomson, K. A. Robertson, D. Gowan, D. Heilman, H. E. Broxmeyer, D. Emanuel, P. Kotylo, Z. Brahmi, and F. O. Smith
Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation
Blood,
October 15, 2000;
96(8):
2703 - 2711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Roux, F. Dumont-Girard, M. Starobinski, C.-A. Siegrist, C. Helg, B. Chapuis, and E. Roosnek
Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity
Blood,
September 15, 2000;
96(6):
2299 - 2303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Amrolia, H. B. Gaspar, A. Hassan, D. Webb, A. Jones, N. Sturt, G. Mieli-Vergani, A. Pagliuca, G. Mufti, N. Hadzic, et al.
Nonmyeloablative stem cell transplantation for congenital immunodeficiencies
Blood,
August 15, 2000;
96(4):
1239 - 1246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Shizuru, I. L. Weissman, R. Kernoff, M. Masek, and Y. C. Scheffold
Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection
PNAS,
July 30, 2000;
(2000)
170279297.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. L. Porter, R. H. Collins Jr, C. Hardy, N. A. Kernan, W. R. Drobyski, S. Giralt, M. E.D. Flowers, J. Casper, A. Leahey, P. Parker, et al.
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
Blood,
February 15, 2000;
95(4):
1214 - 1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Wu, A. Chillemi, E. P. Alyea, E. Orsini, D. Neuberg, R. J. Soiffer, and J. Ritz
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism
Blood,
January 1, 2000;
95(1):
352 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Shizuru, I. L. Weissman, R. Kernoff, M. Masek, and Y. C. Scheffold
Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection
PNAS,
August 15, 2000;
97(17):
9555 - 9560.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|